Pay in 4 interest-free payments of $6.59 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Retatrutide (LY3437943) is a pioneering triple-hormone receptor agonist targeting GIP, GLP-1, and glucagon receptors, setting a new standard in metabolic science
A Letter of Medical Necessity is a document from a licensed healthcare provider that verifies the medical necessity of a product or service, making it eligible to purchase using your HSA or FSA
Nausea, Side Effects, and Evening Injection Strategies Nausea represents the most commonly reported side effect during tirzepatide dose escalation, peaking 2472 hours post-injection and typically resolving by day 5 or 6
Avoid Do not freeze reconstituted solution Freezing causes peptide degradation and aggregation
US$ 27.74
US$ 26.31
US$ 28.23
US$ 25.52
US$ 22.58
